Stenabolic (SR9009) Poudre 1000 mg

Description

DESCRIPTION

Principaux effets :
The product has several key effects on the body:

1. It helps in losing weight.
2. It increases endurance.
3. It protects the heart from disease.
4. It reduces the level of blood cholesterol.
5. It decreases inflammation.
6. It helps reduces anxiety.
7. It helps to decrease tissue damage.

Utilisé pour :
The product has multiple uses, including:

1. Coupe
2. Recompilation

Se combine avec :
The product can be combined with other substances for improved results, such as:

1. Cardarine (GW-501516)
2. Testolone (RAD-140)
3. Ligandrol (LGD-4033)

Contenu:
Here are the technical specifics about its contents. Its CAS number is 1379686-30-2. It has a molar mass of 437.94 g/mol and a formula of C20H24CIN3O4S. The purity of the product is 99%. It should be stored at room temperature. Its storage life is 2 years. Synonyms for the product include SR9009 and Stenabolic.

Dosage:
The exact dosage of the product depends on individual body weight and specific needs. Always start with a lower dosage and carefully monitor your body’s reaction to the product. Consultation with a health professional is necessary before starting any new medication or supplement regimen.

Prudence:
Always keep this product out of the reach of children. If any undesired effects are noticed on the usage of product, seek immediate medical help.

Références scientifiques

| Ingrédient | Titre de l'étude | Auteurs | Année | DOI |
|—|—|—|—|—|
| Stenabolic (SR9009) | Suppression of atherosclerosis by synthetic REV-ERB ligand | Solt, L. A., Wang, Y., Banerjee, S., Hughes, T., Kojetin, D. J., Lundasen, T., Shin, Y., Liu, J., Cameron, M. D., Noel, R., Yoo, S. H., Takahashi, J. S., Butler, A. A., Kamenecka, T. M., and Burris, T. P. | 2012 | 10.1126/scitranslmed.3002708
| Stenabolic (SR9009) | Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behavior | Banerjee, S., Wang, Y., Solt, L. A., Griffett, K., Kazantzis, M., Amador, A., El-Gendy, B. M., Huitron-Resendiz, S., Roberts, A. J., Kamenecka, T. M., Burris, T. P., and Solt, L. A. | 2014 | 10.1038/npp.2013.152
| Stenabolic (SR9009) | The nuclear receptor REV-ERBα regulates Fabp7 and modulates adult hippocampal neurogenesis | Snider, K. H., Sullivan, K. A., Obrietan, K. | 2018 | 10.1371/journal.pone.0197625